Form 8-K - Current report:
SEC Accession No. 0001437749-25-004224
Filing Date
2025-02-18
Accepted
2025-02-18 16:32:02
Documents
14
Period of Report
2025-02-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K rvph20250214_8k.htm   iXBRL 8-K 28514
  Complete submission text file 0001437749-25-004224.txt   176680

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rvph-20250213.xsd EX-101.SCH 3871
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rvph-20250213_def.xml EX-101.DEF 13413
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rvph-20250213_lab.xml EX-101.LAB 17610
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rvph-20250213_pre.xml EX-101.PRE 13390
16 EXTRACTED XBRL INSTANCE DOCUMENT rvph20250214_8k_htm.xml XML 4743
Mailing Address 10080 N WOLFE ROAD SUITE SW3-200 CUPERTINO CA 95014
Business Address 10080 N WOLFE ROAD SUITE SW3-200 CUPERTINO CA 95014 4085018881
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer) CIK: 0001742927 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38634 | Film No.: 25635528
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)